BMY, US1101221083

Bristol Myers Squibb stock falls 1.17 percent at the close

Published on 09/23/2026 at 22:28 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

At the close on September 23, 2026, Bristol Myers Squibb stock traded at USD 61.59 on the NYSE, down 1.17 percent. The prior session closed at USD 62.68, while Goldman Sachs reiterated a Neutral rating.

BMY, US1101221083, Illustration mit AI erstellt.
BMY, US1101221083, Illustration mit AI erstellt.

Bristol Myers Squibb stock closed at USD 61.59 on the NYSE on September 23, 2026, down 1.17 percent from the prior close. The session data reported by Reuters showed the stock at USD 61.59 with a change of USD 0.73 and a negative 1.17 percent move.

September 23, 2026 in numbers

Bristol-Myers Squibb Company (ISIN US1101221083) had closed at USD 62.68 on the NYSE on September 22, 2026, with 2,184,600 shares traded, according to the closing report from Ad-hoc-news. The September 23 close was USD 1.09 below that prior-session level, a decline of 1.74 percent in dollar terms.

Investing.com reported that Goldman Sachs reiterated a Neutral rating on Bristol-Myers Squibb stock. The report cited a stock price of USD 62.25 earlier in the session, which was above the eventual NYSE close.

After-hours session runs until 8:00 p.m. ET

The U.S. extended session continues until 8:00 p.m. ET on September 23, 2026. The next regular U.S. trading session follows on September 24, 2026.

Disclaimer...

en | US1101221083 | BMY | boerse | 70170230 | bgmi